An overview of nonclinical study and evaluation of diagnostic radiopharmaceuticals approved for marketing in the United States in the last two decades

LI Ai-fang; GUANG Hong-mei; WANG Qing-li

doi:10.3969/j.issn.1003-3734.2021.10.001

Home>Articles>An overview of nonclinical study and evaluation of diagnostic radiopharmaceuticals approved for marketing in the United States in the last two decades

DOI: 10.3969/j.issn.1003-3734.2021.10.001

An overview of nonclinical study and evaluation of diagnostic radiopharmaceuticals approved for marketing in the United States in the last two decades

LI Ai-fang

GUANG Hong-mei

WANG Qing-li

Machine-generated Keywords：

Publication Date：2021-05-31

Online Publishing Date：2026-08-14(First online date of this platform, not the publication date of the document)

Pages：6( 865-870 )

Chinese Journal of New Drugs

ISTICPKU

ISSN：1003-3734

Year, Vol.(Issue)：2021,30(10)